Nuclear Medicine Residency Program

Campus History
Founded in 1807 as the fifth medical school in the country, the University of Maryland was first known as the College of Medicine of Maryland. Davidge Hall, its first building, was constructed in 1812 and is the oldest building in the United States used continuously for medical education. The University of Maryland Hospital was established in 1823 as the Baltimore Infirmary, the clinical teaching unit of the School of Medicine. Senior students lived in the hospital while helping care for the patients, and the Baltimore Infirmary offered the first intramural residency program in the United States.


The school became part of the University of Maryland in 1920 when the professional schools in Baltimore merged with the Maryland State College of Agriculture in College Park. The School of Medicine is now one of six professional schools which comprise the university's Campus for the Professions.

Today, the University of Maryland Baltimore Campus is recognized internationally for its outstanding educational, research and training programs. More than 5,300 students are enrolled in degree programs, and more than 8,700 faculty and staff members are employed on the city campus. The 16-square block campus (36 acres) is located a few blocks from the heart of this historic city's business district, Oriole Park at Camden Yards, the Baltimore Ravens' football stadium, and the revitalized Inner Harbor- "Harborplace".

Resident Training Program
The Nuclear Medicine Division of the Department of Radiology provides a two-year ACGME accredited residency in Nuclear Medicine. The residency experience provides a broad understanding of advanced techniques in Nuclear Oncology, Nuclear Cardiology and in molecular imaging. Candidates must meet the preliminary requirements defined by the American Board of Nuclear Medicine.

The close association with the Department of Radiation Oncology and the Greenebaum Cancer Center enhances the program experience in Nuclear Oncology. The integrated University/VA Nuclear Medicine program has advanced attenuation correcting SPECT cameras, as well as dedicated PET and coincidence PET-CT imaging devices. The residency includes training in therapy using I-131 radioiodine, Sr89, Sm153, as well as Y90 microspheres, Y90 monoclonal antibodies and Re188 peptides. There is ample opportunity to participate in FDA approved therapeutic protocols and clinical trials.